questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Thérapie comportementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale : Questions médicales les plus fréquentes",
"headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de maitrise de la colère",
"alternateName": "Anger Management Therapy",
"url": "https://questionsmedicales.fr/mesh/D000067449",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de maitrise de la colère",
"code": {
"@type": "MedicalCode",
"code": "D000067449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse comportementale appliquée",
"alternateName": "Applied Behavior Analysis",
"url": "https://questionsmedicales.fr/mesh/D000072357",
"about": {
"@type": "MedicalCondition",
"name": "Analyse comportementale appliquée",
"code": {
"@type": "MedicalCode",
"code": "D000072357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"url": "https://questionsmedicales.fr/mesh/D001348",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie cognitive",
"alternateName": "Cognitive Behavioral Therapy",
"url": "https://questionsmedicales.fr/mesh/D015928",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie cognitive",
"code": {
"@type": "MedicalCode",
"code": "D015928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie d'acceptation et d'engagement",
"alternateName": "Acceptance and Commitment Therapy",
"url": "https://questionsmedicales.fr/mesh/D064869",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie d'acceptation et d'engagement",
"code": {
"@type": "MedicalCode",
"code": "D064869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Restructuration cognitive",
"alternateName": "Cognitive Restructuring",
"url": "https://questionsmedicales.fr/mesh/D000088686",
"about": {
"@type": "MedicalCondition",
"name": "Restructuration cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000088686",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pleine conscience",
"alternateName": "Mindfulness",
"url": "https://questionsmedicales.fr/mesh/D064866",
"about": {
"@type": "MedicalCondition",
"name": "Pleine conscience",
"code": {
"@type": "MedicalCode",
"code": "D064866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Remédiation cognitive",
"alternateName": "Cognitive Remediation",
"url": "https://questionsmedicales.fr/mesh/D000072466",
"about": {
"@type": "MedicalCondition",
"name": "Remédiation cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000072466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale dialectique",
"alternateName": "Dialectical Behavior Therapy",
"url": "https://questionsmedicales.fr/mesh/D000077252",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale dialectique",
"code": {
"@type": "MedicalCode",
"code": "D000077252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par la relaxation",
"alternateName": "Relaxation Therapy",
"url": "https://questionsmedicales.fr/mesh/D012064",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par la relaxation",
"code": {
"@type": "MedicalCode",
"code": "D012064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méditation",
"alternateName": "Meditation",
"url": "https://questionsmedicales.fr/mesh/D019122",
"about": {
"@type": "MedicalCondition",
"name": "Méditation",
"code": {
"@type": "MedicalCode",
"code": "D019122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chronothérapie sur les phases de sommeil",
"alternateName": "Sleep Phase Chronotherapy",
"url": "https://questionsmedicales.fr/mesh/D055865",
"about": {
"@type": "MedicalCondition",
"name": "Chronothérapie sur les phases de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D055865",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"alternateName": "Behavior Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel F Gros",
"url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros",
"affiliation": {
"@type": "Organization",
"name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA."
}
},
{
"@type": "Person",
"name": "Tanja van der Zweerde",
"url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl."
}
},
{
"@type": "Person",
"name": "Jaap Lancee",
"url": "https://questionsmedicales.fr/author/Jaap%20Lancee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Annemieke van Straten",
"url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands."
}
},
{
"@type": "Person",
"name": "Shireen L Rizvi",
"url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi",
"affiliation": {
"@type": "Organization",
"name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of Extrusion Parameters on the Formation of",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39201355",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25168668"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical validation of electrochemical biosensor for the detection of methylglyoxal in subjects with type-2 diabetes mellitus.",
"datePublished": "2023-11-07",
"url": "https://questionsmedicales.fr/article/37951008",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bioelechem.2023.108601"
}
},
{
"@type": "ScholarlyArticle",
"name": "LC-MS/MS Analysis of Reaction Products of Arginine/Methylarginines with Methylglyoxal/Glyoxal.",
"datePublished": "2023-10-27",
"url": "https://questionsmedicales.fr/article/37888804",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.chemrestox.3c00220"
}
},
{
"@type": "ScholarlyArticle",
"name": "Untargeted metabolomics provide new insights into the implication of Lactobacillus helveticus strains isolated from natural whey starter in methylglyoxal-mediated browning.",
"datePublished": "2023-10-26",
"url": "https://questionsmedicales.fr/article/37986486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodres.2023.113644"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methylglyoxal scavenging capacity of fiber-bound polyphenols from highland barley during colonic fermentation and its modulation on methylglyoxal-interfered gut microbiota.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37699313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.137409"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie comportementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie comportementale",
"description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie comportementale",
"description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie comportementale",
"description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie comportementale",
"description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie comportementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie comportementale",
"description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Pyruvaldehyde&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie comportementale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic pour cette thérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie comportementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver sans traitement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'amélioration avec la thérapie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les parents dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants."
}
},
{
"@type": "Question",
"name": "La prévention est-elle possible à l'âge adulte ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées en thérapie comportementale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs principaux de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques de rechute existent après la thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques peuvent-elles affecter la santé physique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications après la thérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles comportementaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement familial influence-t-il les comportements ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux."
}
}
]
}
]
}
To investigate the impact of extrusion parameters on the formation of...
Methylglyoxal (MG), a highly reactive by-product of glycolysis, is involved in the formation of advanced glycation end-products (AGEs). Elevated levels of MG have been correlated with micro-and macro-...
Methylglyoxal (MGO) and glyoxal (GO) are toxic α-dicarbonyl compounds that undergo reactions with amine containing molecules such as proteins and amino acids and result in the formation of advanced gl...
Hard cheeses may occasionally show a brown discolouration during ripening due to multifactorial phenomena that involve bacteria and give rise to pyrazines arising from methylglyoxal. The present work ...
Methylglyoxal (MGO) scavenging capacity of fiber-bound polyphenols from highland barley during colonic fermentation and its potential role in modulating MGO-induced detrimental effects on gut microbio...
Human exposure to dicarbonyls occurs via ingestion (e.g., food), inhalation (e.g., electronic cigarettes) and dysregulation of endogenous metabolic pathways (e.g., glycolysis). Dicarbonyls are electro...
Commercial sterilization is a thermal processing method commonly used in low-acid canned food products. Meanwhile, heat treatment can significantly promote advanced glycation end product (AGE) formati...
Dicarbonyls are reactive precursors of advanced glycation end-products (AGEs). Dicarbonyls are formed endogenously, but also during food processing. Circulating dicarbonyls are positively associated w...
We aimed to examine the associations of dietary intake of dicarbonyls with insulin sensitivity, β-cell function, and the prevalence of prediabetes or type 2 diabetes....
In 6282 participants (aged 60 ± 9 y; 50% men, 23% type 2 diabetes [oversampled]) of the population-based cohort the Maastricht Study, we estimated the habitual intake of the dicarbonyls methylglyoxal ...
Higher dietary MGO and 3-DG intakes were associated with greater insulin sensitivity after full adjustment, indicated by both a higher Matsuda index (MGO: Std. β [95% CI] = 0.08 [0.04, 0.12]; 3-DG: 0....
Higher habitual consumption of the dicarbonyls MGO and 3-DG was associated with better insulin sensitivity and lower prevalence of type 2 diabetes, after excluding individuals with known diabetes. The...
Although malondialdehyde and methylglyoxal have the same molecular formula, they have different chemistry in forming protein adducts. The major lysine adduct of malondialdehyde in hemoglobin is the...
Maillard flavor compounds, such as 2,3,5-trimethylpyrazine, have been frequently identified in thermally processed food products, such as popcorn and peanuts. However, the origin of the carbon atoms i...